The GAD-7 Anxiety Screening Tool: A Complete Clinician Guide

The Generalized Anxiety Disorder-7 (GAD-7) is the most widely used brief screening tool for anxiety in primary care and mental health settings. Short, free, and easy to interpret, it gives clinicians a quick, reliable measure of anxiety severity and change over time. This guide covers what the GAD-7 measures, how it is scored, how to read the severity bands, and how it works alongside the PHQ-9.

What the GAD-7 measures

The GAD-7 assesses the severity of generalised anxiety symptoms over the past two weeks. Its items were developed around the core features of generalised anxiety disorder - persistent worry, restlessness, irritability, difficulty relaxing, and fearfulness. Although designed for GAD, it also performs reasonably well as a general screen for other common anxiety presentations, including panic, social anxiety, and post-traumatic stress, making it a practical first-line tool.

The seven items and response scale

Respondents rate how often each of the seven symptoms has bothered them over the past two weeks:

• 0 - Not at all
• 1 - Several days
• 2 - More than half the days
• 3 - Nearly every day

The questionnaire takes only a couple of minutes to complete, which is one reason it is so well suited to high-volume screening.

How to score the GAD-7

Summing the seven items produces a total from 0 to 21. Scoring is quick, but manual summation across many patients still invites slips, so automated scoring is increasingly used to guarantee accuracy and consistency across a practice.

GAD-7 severity bands and cut-off

The total maps onto four severity ranges:

• 0-4: Minimal anxiety
• 5-9: Mild anxiety
• 10-14: Moderate anxiety
• 15-21: Severe anxiety

A score of 10 or above is the standard cut-off indicating probable clinically significant anxiety and typically warrants further evaluation. As with all screeners, the GAD-7 supports but does not replace qualified clinical judgement - a positive result guides a fuller assessment rather than delivering a diagnosis.

Using the GAD-7 alongside the PHQ-9

Anxiety and depression frequently co-occur, so the GAD-7 is very commonly administered together with the PHQ-9 depression screener. Used as a pair, they give a rounded picture of a patient's mood and anxiety in under five minutes - an efficient combination for primary care screening and integrated care. Where a broader single instrument is preferred, some clinicians instead use the DASS-21, which measures depression, anxiety, and stress together.

How the GAD-7 compares with other anxiety measures

The GAD-7 is prized for its brevity, whereas the Beck Anxiety Inventory (BAI) is a longer 21-item measure weighted toward somatic symptoms. For rapid triage and routine monitoring, the GAD-7 is usually the tool of choice; when a more detailed picture of physical anxiety symptoms is needed, the BAI may add value. The choice depends on setting, time, and clinical question - see our guide to choosing assessment tools.

Using the GAD-7 digitally

Digital administration lets patients complete the GAD-7 on any device before or during a visit, calculates the total and severity band instantly, and generates a clinician-grade PDF report. Because it is so quick to repeat, the GAD-7 is ideal for measurement-based care: scores plot cleanly over time to show whether treatment is working. Pairing it digitally with the PHQ-9 turns routine screening into a two-minute task that produces a combined report automatically.

Practical tips

• Administer at intake for a baseline, then repeat regularly to monitor progress.
• Pair with the PHQ-9 to capture co-occurring depression.
• Treat a score of 10 or above as a prompt for fuller anxiety assessment.
• Use the item pattern to guide follow-up questions, not just the total.
• Use digital scoring to remove errors and cut administrative time.

Key takeaways

• The GAD-7 is a 7-item screener for generalised anxiety, scored 0-21.
• Severity bands are 0-4 minimal, 5-9 mild, 10-14 moderate, and 15-21 severe.
• A score of 10 or above is the standard cut-off for probable clinically significant anxiety.
• It pairs naturally with the PHQ-9 to screen for co-occurring depression.
• Digital administration adds speed, accuracy, and easy tracking over time.